CEP-751 inhibits trk receptor tyrosine kinase activityin vitro and exhibits anti-tumor activity
Anna Marie Camoratto(Avalon Pharma (United States)), Craig A. Dionne, Anna C. Maroney(AbbVie (United States)), Jitesh P. Jani, Christa Y. Sanders, Chikara Murakata(Kyowa Kirin (Japan)), Jeffry L. Vaught(Kyowa Kirin (Japan)), Nicola T. Neff(Kyowa Kirin (Japan)), Thelma S. Angeles, John T. Isaacs(Brady (Norway))
International Journal of Cancer
August 7, 1997
Cited by 76
Related Papers
Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells
|Journal of Medicinal Chemistry|2005|430
Motoneuron Apoptosis Is Blocked by CEP-1347 (KT 7515), a Novel Inhibitor of the JNK Signaling Pathway
|Journal of Neuroscience|1998|293
The MLK Family Mediates c-Jun N-Terminal Kinase Activation in Neuronal Apoptosis
|Molecular and Cellular Biology|2001|268
The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells
|Cancer Research|2008|233